NomadX announces appointment of Kevin Pelletier as Chief Technology Officer

NomadX, a pioneer in disruptive pathogen, allergen, and chemical detection technologies, is pleased to announce the appointment of Kevin Pelletier as its Chief Technology Officer (CTO).

With over 20 years of experience in thermal, mechanical, and optical engineering, as well as a proven track record in medical device invention and successful company exits, Mr. Pelletier brings a wealth of expertise to the NomadX team.

Mr. Pelletier has built a distinguished career at the intersection of engineering and innovation. Most recently, he served as the CEO and Founder of Photon Ink, LLC, a design and engineering firm specializing in LED product development, optical design, and project engineering. His extensive background includes significant contributions to photometry, rapid development, and prototyping. His technical acumen and visionary leadership have consistently driven technological advancements and operational excellence.

Commenting on his new role, Kevin Pelletier said, "I'm thrilled to join NomadX at such a pivotal time in the company's growth. I look forward to building an outstanding team and contributing to our success."

NomadX's disruptive technology offers swift, accurate, and cost-effective detection of pathogens, allergens, and chemicals. The technology is application-agnostic, making it versatile for use in food, water, air, as well as certain medical and pharmaceutical diagnostic applications.